ACA
Overvalued by 25.7% based on the discounted cash flow analysis.
Market cap | $4.53 Billion |
---|---|
Enterprise Value | $6.13 Billion |
Dividend Yield | $0.20 (0.22%) |
Earnings per Share | $1.92 |
Beta | 0.98 |
Outstanding Shares | 48,900,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 48.97 |
---|---|
PEG | 158.38 |
Price to Sales | 1.71 |
Price to Book Ratio | 1.85 |
Enterprise Value to Revenue | 2.29 |
Enterprise Value to EBIT | 32.7 |
Enterprise Value to Net Income | 66 |
Total Debt to Enterprise | 0.29 |
Debt to Equity | 0.73 |
No data
No data